相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Use of genomic signatures in therapeutics development in oncology and other diseases
R. Simon et al.
PHARMACOGENOMICS JOURNAL (2006)
Adaptive signature design: An adaptive clinical trial design for generating and prospectively testing a gene expression signature for sensitive patients
B Freidlin et al.
CLINICAL CANCER RESEARCH (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Roadmap for developing and validating therapeutically relevant genomic classifiers
R Simon
JOURNAL OF CLINICAL ONCOLOGY (2005)
Discovering statistically significant pathways in expression profiling studies
L Tian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Gene expression patterns and profile changes pre- and post-erlotinib treatment in patients with metastatic breast cancer
SX Yang et al.
CLINICAL CANCER RESEARCH (2005)
Prediction error estimation: a comparison of resampling methods
AM Molinaro et al.
BIOINFORMATICS (2005)
Clinical trial designs for predictive marker validation in cancer treatment trials
DJ Sargent et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
On the efficiency of targeted clinical trials
A Maitournam et al.
STATISTICS IN MEDICINE (2005)
Prediction of cancer outcome with microarrays: a multiple random validation strategy
S Michiels et al.
LANCET (2005)
Molecular classification of tamoxifen-resistant breast carcinomas by gene expression profiling
MPHM Jansen et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Clinical trial design for microarray predictive marker discovery and assessment
L Pusztai et al.
ANNALS OF ONCOLOGY (2004)
Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer
M Ayers et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen
XJ Ma et al.
CANCER CELL (2004)
Evaluating the efficiency of targeted designs for randomized clinical trials
R Simon et al.
CLINICAL CANCER RESEARCH (2004)
Diagnostic and prognostic prediction using gene expression profiles in high-dimensional microarray data
R Simon
BRITISH JOURNAL OF CANCER (2003)
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
C Sotiriou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
A gene-expression signature as a predictor of survival in breast cancer.
MJ van de Vijver et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
A Rosenwald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Initiating oncogenic event determines gene-expression patterns of human breast cancer models
KV Desai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
A paradigm for class prediction using gene expression profiles
MD Radmacher et al.
JOURNAL OF COMPUTATIONAL BIOLOGY (2002)
Significance analysis of microarrays applied to the ionizing radiation response
VG Tusher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: Clinical practice guidelines of the American Society of Clinical Oncology
RC Bast et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)